FDA's Spielberg Wants NIH/FDA Collaborations To Focus On Problem-Solving
This article was originally published in The Pink Sheet Daily
Executive Summary
NIH research could help FDA overcome pressing scientific hurdles and provide a rational basis for regulatory decision-making, the agency's new deputy commissioner for medical products and tobacco tells the Alliance for a Stronger FDA.
You may also be interested in...
Learning To Drive The ‘Chariot’: FDA Deputy Califf’s New Role
Renowned clinical trialist and cardiologist will become deputy commissioner for medical products and tobacco, a complicated and challenging position.
Learning To Drive The ‘Chariot’: FDA Deputy Califf’s New Role
Renowned clinical trialist and cardiologist will become deputy commissioner for medical products and tobacco, a complicated and challenging position.
Will NCATS Become More Than The Sum Of Its Parts?
NCATS may be new, but most of its efforts to facilitate the search for methods and technologies to reduce the cost of drug development will be made through pre-existing funding and programs.